GridAI Technologies Corp. (GRDX) Stock Analysis
NASDAQHealthcareBiotechnology
What GridAI Technologies Corp. does
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Key metrics
ETFs linked to GRDX
Broad-market and Healthcare sector ETFs an investor holding GridAI Technologies Corp. is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how GRDX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze GRDX in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for GridAI Technologies Corp.?
- GridAI Technologies Corp. trades under the ticker GRDX on NASDAQ.
- Which exchange is GRDX listed on?
- GRDX is listed on NASDAQ.
- What sector does GridAI Technologies Corp. operate in?
- GridAI Technologies Corp. is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze GRDX in a portfolio?
- PortView shows GRDX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.